[Home ] [Archive]    
:: Volume 2, Issue 2 (6-2017) ::
jogcr 2017, 2(2): 0-0 Back to browse issues page
A Review of Recent Findings for Obstetricians about Combined Oral Contraceptive Pills
Gynecologist Oncologist, Department of Obstetrics and Gynecology, Iran University of Medical Sciences, Tehran, Iran
Abstract:   (660 Views)
Combined oral contraceptive pills (OCPs) contain estrogen (ethinylestradiol) and progesterone (first-generation levonorgestrel and fourth-generation drospirenone). Progesterone has peripheral effects on the endometrium, fallopian tubes, and cervix and can promote contraception. These pills are used to prevent pain caused by Mittelschmerz syndrome and endometriosis and to treat hyperandrogenism. To prescribe contraceptives, it is adequate to take the patient’s medical history and blood pressure. In the absence of risk factors, patients should be followed-up by history-taking, blood pressure measurement, urinalysis, Pap smear test, and examination of breasts, pelvis, and liver. The risk of venous thrombosis in new OCPs is twice higher than that of older generations and usually occurs in the first year of consumption. The only absolute contraindications for the use of new OCPs include chronic and acute cholestatic liver diseases. In fact, use of new OCPs increases the risk of liver adenoma, but not hepatocellular carcinoma. On the other hand, in female patients with genital tract cancers, risk of endometrial and ovarian epithelial cancers decreases following the use of OCPs. However, the risk of cervical adenocarcinoma increases after 5 years of consumption due to cervical eversion and impaired vitamin metabolism. These pills are contraindicated in women above 35 years who smoke more than 15 cigarettes daily or have uncontrolled hypertension, venous thromboembolism, migraine aura, severe hyperglycemia, breast cancer (diagnosed or suspected), or diabetes mellitus associated with cardiovascular diseases.
Keywords: Oral Contraceptive Pills, Contraception, Pregnancy, Thrombosis
Full-Text [PDF 117 kb]   (217 Downloads)    
Systematic Review: Original Research | Subject: General
Received: 2018/05/4 | Accepted: 2018/12/29 | Published: 2018/12/29
Add your comments about this article
Your username or Email:


XML     Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Aminimoghaddam < < H ". A Review of Recent Findings for Obstetricians about Combined Oral Contraceptive Pills . jogcr. 2017; 2 (2)
URL: http://jogcr.com/article-1-141-en.html

Volume 2, Issue 2 (6-2017) Back to browse issues page
Journal of Obstetrics, Gynecology and Cancer Research (JOGCR)
Persian site map - English site map - Created in 0.06 seconds with 31 queries by YEKTAWEB 3925